14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $35.86 $42.36 Thursday, 25th Apr 2024 CLDX stock ended at $36.26. This is 2.05% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.61% from a day low at $35.86 to a day high of $37.16.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Oct 25, 2023 $24.07 $24.07 $23.14 $23.50 539 221
Oct 24, 2023 $24.44 $25.15 $24.20 $24.45 380 600
Oct 23, 2023 $26.00 $26.33 $23.37 $24.32 446 664
Oct 20, 2023 $24.47 $24.87 $23.98 $24.43 377 796
Oct 19, 2023 $24.11 $24.45 $23.49 $24.39 368 175
Oct 18, 2023 $24.04 $24.79 $23.77 $24.00 748 374
Oct 17, 2023 $26.56 $27.07 $24.53 $24.62 808 381
Oct 16, 2023 $26.39 $26.85 $25.69 $26.78 493 958
Oct 13, 2023 $26.53 $27.01 $25.53 $26.14 561 847
Oct 12, 2023 $27.81 $27.81 $26.10 $26.49 443 794
Oct 11, 2023 $28.39 $28.58 $27.40 $28.01 239 091
Oct 10, 2023 $27.80 $28.58 $27.71 $28.28 253 584
Oct 09, 2023 $27.64 $27.85 $26.83 $27.76 168 931
Oct 06, 2023 $27.18 $27.99 $26.99 $27.92 360 965
Oct 05, 2023 $26.53 $27.62 $26.21 $27.56 448 638
Oct 04, 2023 $26.25 $26.54 $25.21 $26.50 546 370
Oct 03, 2023 $27.05 $27.00 $25.82 $26.26 471 846
Oct 02, 2023 $27.60 $27.85 $26.89 $27.37 528 923
Sep 29, 2023 $28.21 $28.33 $27.03 $27.52 340 721
Sep 28, 2023 $27.26 $28.31 $27.10 $27.99 488 079
Sep 27, 2023 $26.84 $27.41 $26.32 $27.34 481 293
Sep 26, 2023 $25.98 $26.76 $25.98 $26.51 402 404
Sep 25, 2023 $25.43 $26.06 $24.89 $25.84 433 869
Sep 22, 2023 $26.34 $26.34 $25.20 $25.45 417 007
Sep 21, 2023 $26.00 $26.38 $25.66 $26.24 317 957
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT